EFPIA’s 2022 Patient WAIT Indicator tracks the availability of new medicines and length of time it takes patients to get them in 37 countries in the EU and EEA. Figures show that, on average, a new medicine will reach patients fastest in Germany in 128 days; this compares with 918 days in Romania and 1351 days in Malta, with a European average of 517 days.
In Europe, the average rate of availability of medicines across all therapy areas has dropped to 47% - down 2% on last year’s figures. Disparities persist between Northern and Western Europe and Southern and Eastern Europe - with an 80% average variance in availability.
Find out more about our commitments to
help reduce patient access inequalities.